TD Cowen Maintains Buy on Biodesix, Raises Price Target to $40

Benzinga · 4d ago
TD Cowen analyst Dan Brennan maintains Biodesix (NASDAQ:BDSX) with a Buy and raises the price target from $30 to $40.